news: competitor oversubscribed, smaller. Heartware to list Monday. Reported oversubscribed in today's The Australian and Daily Telegraph.
Telegraph reports 'Its first product the HVAD is expected to start human trials in the final quarter of 2005 with the first sales planned for 2007. It is almost a third of the size of comparable devices.
The company's scond pump the prototype MVAD is about a 10th the size of the HVAD.
Bear in mind that it has the same popular mechanism is a fraction of the size, cost and installing operation time and it has a mkt cap of $76m.
Think about it with VCR as I remember around $240m and no pipeline of products like the MVAD.
Don't worry about Heartware working. It has done the relevant trials and it has the same workings as VCR and similar products.
VCR
ventracor limited
heartware ipo, page-11
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)